Definitive Contract HHSN268200736193C
- Not listed
- The University of Pittsburgh has been awarded a $128,550.35 cost-no-fee delivery order contract by the National Heart, Lung, and Blood Institute, which is part of the National Institutes of Health, a civilian federal agency. This contract is for the LUNG TISSUE RESEARCH CONSORTIUM CLINICAL CENTER, specifically Task Order 2 which runs from March 1, 2017 to February 28, 2018. The contract does not have a set-aside designation. As a large public research university, the University of Pittsburgh...
- The University of Pittsburgh was awarded a $52,709 definitive contract by the National Heart Lung and Blood Institute, a civilian agency within the National Institutes of Health, to conduct the National Emphysema Treatment Trial. This research contract does not have a set-aside designation. The University of Pittsburgh, a major recipient of federal research grants and contracts, serves as the prime contractor for this project. The contract supports work related to emphysema treatment, which is a...
- The National Heart Lung and Blood Institute (NHLBI) awarded a $5,044,699.36 cost-reimbursement contract to the University of Pittsburgh (Pitt) for the "PUMPS FOR KIDS, INFANTS, AND NEONATES (PUMPKIN)" project. This definitive contract, awarded on January 15, 2010, has a completion date of May 1, 2015 and does not have a set-aside designation. Pitt, as a large non-profit research university, frequently partners with government agencies on federally funded projects. This contract...
- This federal contract award is for the Long Term Oxygen Treatment Trial, a research study funded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The contract, a Definitive Contract with cost-no-fee pricing, was awarded to The Johns Hopkins University, a private non-profit research university, on October 31, 2006, with a ceiling value of $15,824,931.90 and a completion date of April 30, 2017. The contract did not have a set-aside...
- This is a $17,695,468.14 federal contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health, to the University of Pittsburgh (Pitt). The contract is for "PEDIATRIC CIRCULATORY SUPPORT" research and does not have a set-aside designation. Pitt, a large non-profit research university, frequently partners with government agencies on federally funded research projects in biomedical sciences and other disciplines. This contract...
- This is a definitive contract awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, to the Regents of the University of Michigan for the "Long Term Oxygen Treatment Trial" with a ceiling value of $2,882,600.31. The contract was awarded on October 31, 2006, with a final completion date of March 31, 2016. This contract was not set aside for any specific business type. Through past federal contracts and grants,...
- This is a definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Duke University for the "LONG TERM OXYGEN TREATMENT TRIAL". The contract has a total ceiling value of $2,316,894.97 and was awarded on October 31, 2006, with a final completion date of June 30, 2016. Duke University, as the prime contractor, will provide clinical research services related to long-term oxygen treatment. The contract...
- This is a delivery order awarded by the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute to the University of Pittsburgh for the Lung Tissue Research Consortium (LTRC) Clinical Center. The order, valued at $124,488.98, covers the period from March 1, 2018, to February 28, 2019. The University of Pittsburgh is performing the work in Pittsburgh, Pennsylvania, and the contract does not have a set-aside designation. The University of Pittsburgh is a state-related...
- This is a Cost No Fee definitive contract awarded to the University of Alabama at Birmingham (UAB) by the National Heart Lung and Blood Institute, a civilian agency within the Department of Health and Human Services, for the Long Term Oxygen Treatment Trial. The contract has a ceiling value of $3,648,599.89 and a period of performance ending on March 31, 2016. The contract has no set-aside designation. As a leading research university, UAB has extensive experience conducting biomedical...
- This is a definitive contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to the University of Washington (UW) for the Long-Term Oxygen Treatment Trial (LOTT) - Regional Clinical Center. The contract, which does not have a set-aside designation, has a ceiling value of $1,134,440.29 and runs through March 31, 2016. The LOTT is a major study focused on long-term oxygen treatment. As a Regional Clinical Center, UW is responsible for providing specialized...
This federal contract award was issued by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to the University of Pittsburgh, a non-profit educational institution, for the "Long Term Oxygen Treatment Trial". The definitive cost-no-fee contract has a ceiling value of $2,552,564.24 and a completion date of June 30, 2016. The contract does not have a set-aside designation. The University of Pittsburgh, a major recipient of federal research funding, is serving as the prime contractor on this project focused on long-term oxygen treatment. The contract allows the NHLBI, which supports a broad biomedical research portfolio, to rapidly initiate new preclinical studies in support of its mission to research, treat, and prevent diseases.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 15 | Change Order | ($88k) | 4/18/17 | |
| 14 | Change Order | $0 | 4/5/16 | |
| 13 | Exercise an Option | $9.8k | 12/22/15 | |
| 12 | Funding Only Action | ($264k) | 6/8/15 | |
| 11 | Supplemental Agreement for work within scope | $156.8k | 12/16/14 |